Microphthalmia-associated transcription factor (MITF) IVD, antibody

This category includes laboratory reagents designed to detect the presence of microphthalmia-associated transcription factor (MITF) in patient samples such as tissue or blood. These devices use antibodies that specifically bind to MITF to support the diagnosis and monitoring of certain cancers, particularly melanoma, by identifying the expression of this protein in clinical specimens.

Devices in this category are in vitro diagnostic (IVD) tools that rely on antibody-based detection methods and are intended for use in clinical laboratories. They are regulated as IVDs and must meet performance and safety standards for analytical validity, but their regulatory classification depends on the jurisdiction and intended use, not the category itself.